BBA
CRDL

Baader Bank Aktiengesellschaft’s Cardiol Therapeutics CRDL Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.2K Buy
+15,932
New +$16.4K ﹤0.01% 406
2025
Q4 		– Sell
-13,825
Closed -$6.66K – 484
2025
Q3 		$6.66K Buy
+13,825
New +$16.8K ﹤0.01% 476
2024
Q3 		– Sell
-29,028
Closed -$34.4K – 468
2024
Q2 		$34.4K Buy
+29,028
New +$61.6K ﹤0.01% 381

Other funds holding CRDL

MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
IA
Integrity Alliance Urbandale, Iowa $2.64B AUM 16.75% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baader Bank Aktiengesellschaft's CRDL Position: Q1 2026 in Review

Baader Bank Aktiengesellschaft opened a new position in Cardiol Therapeutics (CRDL) in Q1 2026: 15,932 shares worth $10.2K. The stake represents ﹤0.01% of the portfolio and ranks #406 among its holdings. This is a return to the name: Baader Bank Aktiengesellschaft previously reported a position in CRDL as recently as Q3 2025.

Baader Bank Aktiengesellschaft first reported a position in CRDL in Q2 2024 and has held it in 3 quarters since. The position peaked at $34.4K in Q2 2024. 47 funds tracked by Wall St. Rank hold CRDL as of Q1 2026.

  • Baader Bank Aktiengesellschaft held 15,932 shares of Cardiol Therapeutics worth $10.2K as of Q1 2026.
  • Cardiol Therapeutics was a new Baader Bank Aktiengesellschaft position in Q1 2026.
  • Cardiol Therapeutics made up ﹤0.01% of Baader Bank Aktiengesellschaft's portfolio in Q1 2026, its #406 holding.
  • Baader Bank Aktiengesellschaft first reported a position in Cardiol Therapeutics in Q2 2024 and has held it in 3 quarters since.
  • Baader Bank Aktiengesellschaft's Cardiol Therapeutics position peaked at $34.4K in Q2 2024.
  • 47 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q1 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2026, filed 8 May 2026.